source
- FDA urged to boost US access to new and experimental drugs as trials shift to ChinaThe piece highlights that the FDA has taken steps such as launching Operation TrialBlazer and tightening review of foreign clinical data, but argues that further action is required to keep the Unit…
- Lilly adds $870M to Gate Bioscience partnership to pursue new drug targetsEli Lilly is expanding its collaboration with Gate Bioscience, adding a new financial commitment of more than $870 million. The original July 2025 agreement gave Lilly access to Gate’s "Molecular…